© The Rockefeller University Press, 0022-1007/1997/7/313/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 2, July 21, 1997 313-323
Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)–mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1)
Qian Yuan*,||,
K. Frank Austen*,||,
Daniel S. Friend
,
Matthew Heidtman||, and
Joshua A. Boyce*,
,||
From the * Department of Medicine,
Department of Pathology, and
Department of Pediatrics, Harvard Medical School, the || Division of Rheumatology, Immunology, and Allergy, and the
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115
We evaluated mature peripheral blood eosinophils for their expression of the surface tyrosine kinase, c-kit, the receptor for the stromal cell–derived cytokine, stem cell factor (SCF). Cytofluorographic analysis revealed that c-kit was expressed on the purified peripheral blood eosinophils from 8 of 8 donors (4 nonatopic and 4 atopic) (mean channel fluorescence intensity 2.0– 3.6-fold, average 2.8 ± 0.6-fold, greater than the negative control). The uniform and selective expression of c-kit by eosinophils was confirmed by immunohistochemical analysis of peripheral blood buffy coats. The functional integrity of c-kit was demonstrated by the capacity of 100 ng/ml (5 nM) of recombinant human (rh) SCF to increase eosinophil adhesion to 3, 10, and 30 µg/ml of immobilized FN40, a 40-kD chymotryptic fragment of plasma fibronectin, in 15 min by 7.7 ± 1.4-, 5.3 ± 3.3-, and 5.4 ± 0.2-fold, respectively, and their adhesion to 0.1, 0.5, and 1.0 µg/ml vascular cell adhesion molecule-1 (VCAM-1), by 12.7 ± 9.2-, 3.8 ± 2.5-, and 1.7 ± 0.6-fold, respectively. The SCF-stimulated adhesion occurred without concomitant changes in surface integrin expression, thereby indicating an avidity-based mechanism. rhSCF (100 ng/ml, 5 nM) was comparable to rh eotaxin (200 ng/ml, 24 nM) in stimulating adhesion. Cell adhesion to FN40 was completely inhibited with antibodies against the
4 and β1 integrin subunits, revealing that the SCF/c-kit adhesion effect was mediated by a single integrin heterodimer, very late antigen 4 (VLA-4). Thus, SCF represents a newly recognized stromal ligand for the activation of eosinophils for VLA-4–mediated adhesion, which could contribute to the exit of these cells from the blood, their tissue localization, and their prominence in inflammatory lesions.
Address correspondence to Qian Yuan, M.D., Ph.D., Harvard Medical School, Seeley G. Mudd Building, Room 618, 250 Longwood Avenue, Boston, MA 02115. Phone: 617-432-1995; FAX: 617-432-0979.
1Abbreviations used in this paper: BCECF-AM, 2',7'-bis-(2-carboxyethyl)- 5-(and 6)-carboxyfluorescein acetoxymethyl ester; BMMC, bone marrow–derived mast cells; CS-1, connecting segment-1; HSA, human serum albumin; MACS, magnetic cell separation; MFI, mean fluorescence intensity; rh, recombinant human; SCF, stem cell factor; VCAM, vascular cell adhesion molecule; VLA, very late antigen.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Dolgachev, V., Petersen, B. C., Budelsky, A. L., Berlin, A. A., Lukacs, N. W.
(2009). Pulmonary IL-17E (IL-25) Production and IL-17RB+ Myeloid Cell-Derived Th2 Cytokine Production Are Dependent upon Stem Cell Factor-Induced Responses during Chronic Allergic Pulmonary Disease. J. Immunol.
183: 5705-5715
[Abstract]
[Full Text]
-
Takagi, Y., Hashimoto, N., Phan, S. H., Imaizumi, K., Matsuo, M., Nakashima, H., Hashimoto, I., Hayashi, Y., Kawabe, T., Shimokata, K., Hasegawa, Y.
(2009). Erythromycin-induced CXCR4 expression on microvascular endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
297: L420-L431
[Abstract]
[Full Text]
-
Dolgachev, V., Berlin, A. A., Lukacs, N. W.
(2008). Eosinophil Activation of Fibroblasts from Chronic Allergen-Induced Disease Utilizes Stem Cell Factor for Phenotypic Changes. Am. J. Pathol.
172: 68-76
[Abstract]
[Full Text]
-
Dolgachev, V., Thomas, M., Berlin, A., Lukacs, N. W.
(2007). Stem cell factor-mediated activation pathways promote murine eosinophil CCL6 production and survival. J. Leukoc. Biol.
81: 1111-1119
[Abstract]
[Full Text]
-
Ishikawa, Y., Yoshimoto, T., Nakanishi, K.
(2006). Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness. Int Immunol
18: 847-855
[Abstract]
[Full Text]
-
Moriyama, M., Fukuyama, S., Inoue, H., Matsumoto, T., Sato, T., Tanaka, K., Kinjyo, I., Kano, T., Yoshimura, A., Kojima, M.
(2006). The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. Am. J. Physiol. Lung Cell. Mol. Physiol.
290: L971-L977
[Abstract]
[Full Text]
-
Berlin, A. A., Lukacs, N. W.
(2005). Treatment of Cockroach Allergen Asthma Model with Imatinib Attenuates Airway Responses. Am. J. Respir. Crit. Care Med.
171: 35-39
[Abstract]
[Full Text]
-
Cortes, J., Ault, P., Koller, C., Thomas, D., Ferrajoli, A., Wierda, W., Rios, M. B., Letvak, L., Kaled, E. S., Kantarjian, H.
(2003). Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood
101: 4714-4716
[Abstract]
[Full Text]
-
Pardanani, A., Reeder, T., Porrata, L. F., Li, C.-Y., Tazelaar, H. D., Baxter, E. J., Witzig, T. E., Cross, N. C. P., Tefferi, A.
(2003). Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood
101: 3391-3397
[Abstract]
[Full Text]
-
Oliveira, S. H. P., Taub, D. D., Nagel, J., Smith, R., Hogaboam, C. M., Berlin, A., Lukacs, N. W.
(2002). Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. Blood
100: 4291-4297
[Abstract]
[Full Text]
-
Temkin, V., Kantor, B., Weg, V., Hartman, M.-L., Levi-Schaffer, F.
(2002). Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release. J. Immunol.
169: 2662-2669
[Abstract]
[Full Text]
-
Hartman, M.-L., Piliponsky, A. M., Temkin, V., Levi-Schaffer, F.
(2001). Human peripheral blood eosinophils express stem cell factor. Blood
97: 1086-1091
[Abstract]
[Full Text]
-
Klein, A., Talvani, A., Cara, D. C., Gomes, K. L., Lukacs, N. W., Teixeira, M. M.
(2000). Stem Cell Factor Plays a Major Role in the Recruitment of Eosinophils in Allergic Pleurisy in Mice Via the Production of Leukotriene B4. J. Immunol.
164: 4271-4276
[Abstract]
[Full Text]
-
Chung, K F, Barnes, P J
(1999). Cytokines in asthma. Thorax
54: 825-857
[Full Text]
-
Ochi, H., Hirani, W. M., Yuan, Q., Friend, D. S., Austen, K. F., Boyce, J. A.
(1999). T Helper Cell Type 2 Cytokine-Mediated Comitogenic Responses and Ccr3 Expression during Differentiation of Human Mast Cells in Vitro. JEM
190: 267-280
[Abstract]
[Full Text]
-
Giembycz, M. A., Lindsay, M. A.
(1999). Pharmacology of the Eosinophil. Pharmacol. Rev.
51: 213-340
[Abstract]
[Full Text]
-
Campbell, E., Hogaboam, C., Lincoln, P., Lukacs, N. W.
(1999). Stem Cell Factor-Induced Airway Hyperreactivity in Allergic and Normal Mice. Am. J. Pathol.
154: 1259-1265
[Abstract]
[Full Text]
-
Barnes, P. J., Chung, K. F., Page, C. P.
(1998). Inflammatory Mediators of Asthma: An Update. Pharmacol. Rev.
50: 515-596
[Abstract]
[Full Text]
-
Yuan, Q., Gurish, M. F., Friend, D. S., Austen, K. F., Boyce, J. A.
(1998). Cutting Edge: Generation of a Novel Stem Cell Factor-Dependent Mast Cell Progenitor. J. Immunol.
161: 5143-5146
[Abstract]
[Full Text]
-
Dutt, P., Wang, J.-F., Groopman, J. E.
(1998). Stromal Cell-Derived Factor-1{alpha} and Stem Cell Factor/kit Ligand Share Signaling Pathways in Hemopoietic Progenitors: A Potential Mechanism for Cooperative Induction of Chemotaxis. J. Immunol.
161: 3652-3658
[Abstract]
[Full Text]
-
SPOELSTRA, F. M., HOVENGA, H., NOORDHOEK, J. A., POSTMA, D. S., KAUFFMAN, H. F.
(1998). Changes in CD11b and L-selectin Expression on Eosinophils Are Mediated by Human Lung Fibroblasts In Vitro. Am. J. Respir. Crit. Care Med.
158: 769-777
[Abstract]
[Full Text]